Distinct mesenchymal progenitor cell subsets in the adult human synovium

Rheumatology

Volumn 48, Issue 9, 2009, Pages 1057-1064

  Karystinou, Alexandra ^a   Dell'Accio, Francesco ^b   Kurth, Tobias B A ^a   Wackerhage, Henning ^a   Khan, Ilyas M ^c   Archer, Charles W ^c   Jones, Elena A ^d   Mitsiadis, Thimios A ^e   de Bari, Cosimo ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Chondrogenesis; Clones; Mesenchymal stem cells; Osteogenesis; Regenerative medicine; Synovium

Indexed keywords

BETA GALACTOSIDASE; TELOMERASE;

ADIPOGENESIS; ADULT; AGED; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SUBPOPULATION; CHONDROGENESIS; CLINICAL ARTICLE; CLONAL VARIATION; CLONE; CONTROLLED STUDY; DILUTION; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE AMPLIFICATION; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; KNEE; MALE; MESENCHYMAL STEM CELL; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SENESCENCE; SOUTHERN BLOTTING; STAINING; SYNOVIUM; TELOMERE; CELL AGING; CELL CULTURE; CELL DIVISION; CYTOLOGY; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; PHYSIOLOGY; ULTRASTRUCTURE;

AGED; AGED, 80 AND OVER; CELL AGING; CELL DIVISION; CELLS, CULTURED; CHONDROGENESIS; FEMALE; HUMANS; IMMUNOPHENOTYPING; KNEE JOINT; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOGENESIS; SYNOVIAL MEMBRANE; TELOMERASE; TELOMERE;

EID: 70349784736     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep192     Document Type: Article

References (46)

1. De Bari C, Dell'Accio F. Mesenchymal stem cells in rheumatology: a regenerative approach to joint repair. Clin Sci 2007;113:339-48.
2. De Bari C, Dell'Accio F. Cell therapy: a challenge in modern medicine. Biomed Mater Eng 2008;18(Suppl. 1):S11-17.
3. De Bari C, Pitzalis C, Dell'Accio F. Reparative medicine: from tissue engineering to joint surface regeneration. Regen Med 2006;1:59-69.
4. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 2006;355:1274-7.
5. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
6. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 2001;7:259-64.
7. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-4.
8. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001;44:1928-42.
9. Jones EA, English A, Henshaw K et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 2004;50:817-27.
10. De Bari C, Dell'Accio F, Vanlauwe J et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006;54:1209-21.
11. Nakahara H, Bruder SP, Haynesworth SE et al. Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone 1990;11:181-8.
12. De Bari C, Dell'Accio F, Luyten FP. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 2001;44:85-95.
13. Asakura A, Komaki M, Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001;68:245-53.
14. Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-28.
15. Dell'Accio F, De Bari C, Luyten FP. Microenvironment and phenotypic stability specify tissue formation by human articular cartilage-derived cells in vivo. Exp Cell Res 2003;287:16-27.
16. Alsalameh S, Amin R, Gemba T, Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 2004;50:1522-32.
17. Dowthwaite GP, Bishop JC, Redman SN et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci 2004;117:889-97.
18. De Bari C, Dell'Accio F, Vandenabeele F, Vermeesch JR, Raymackers JM, Luyten FP. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 2003;160:909-18.
19. De Bari C, Dell'Accio F, Karystinou A et al. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 2008;58:240-50.
20. De Bari C, Dell'Accio F, Luyten FP. Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum 2004;50:142-50.
21. Ho AD, Wagner W, Franke W. Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 2008;10:320-30.
22. Jones PH, Watt FM. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 1993;73:713-24.
23. Dimri GP, Lee X, Basile G et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-7.
24. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005;52:2521-9.
25. Hou M, Xu D, Bjorkholm M, Gruber A. Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Clin Chem 2001;47:519-24.
26. Jones EA, Kinsey SE, English A et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002;46:3349-60.
27. Quarto R, Mastrogiacomo M, Cancedda R et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344:385-6.
28. Vacanti CA, Bonassar LJ, Vacanti MP, Shufflebarger J. Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 2001;344:1511-14.
29. Warnke PH, Springer IN, Wiltfang J et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 2004;364:766-70.
30. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002;10:199-206.
31. Horwitz EM, Gordon PL, Koo WK et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99:8932-7.
32. Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5:309-13.
33. Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 2000;97:3213-18.
34. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly selfrenewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 2001;98:7841-5.
35. Bianchi A, Shore D. How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex. Mol Cell 2008;31:153-65.
36. Yamanishi Y, Boyle DL, Green DR et al. p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis. Arthritis Res Ther 2005;7:R12-18.
37. Blank M, Shiloh Y. Programs for cell death: apoptosis is only one way to go. Cell Cycle 2007;6:686-95.
38. Brookes S, Rowe J, Ruas M et al. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J 2002;21:2936-45.
39. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005;37:961-76.
40. Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev 2008;88:557-79.
41. Herbig U, Sedivy JM. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech Ageing Dev 2006;127:16-24.
42. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004;22:675-82.
43. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 2007;109: 1743-51.
44. Sudo K, Kanno M, Miharada K et al. Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fibroblast-like cell populations. Stem Cells 2007;25:1610-17.
45. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-6.
46. Mareddy S, Crawford R, Brooke G, Xiao Y. Clonal isolation and characterization of bone marrow stromal cells from patients with osteoarthritis. Tissue Eng 2007;13:819-29.